Luc Pascal (Observer, BNP Paribas Developpement representative)
Michel Pourcelot (Observer, SOFIPACA representative)
Christophe Somaini (Observer, Amundi Private Equity Funds representative)
In 2015, HalioDx has completed a Round A of financing of 8.5 million euros combining the founders and leading capital venture funds : MI Care S.A., SHAM Innovation Santé advised by Turenne Capital, Sofipaca and BNP Paribas Développement.
In 2018, HalioDx has completed a Round B of financing of 18.5 million euros combining 3 new investors PSIM fund managed by Bpifrance, Amundi Private Equity Funds and Quest for Growth managed by Capricorn venture Partners, with the 4 historical investors : MI Care S.A., Sham Innovation Santé/Turenne, BNP Paribas Développement and Sofipaca.